Etomidate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Etomidate Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Oct 5, 2022.
Shortage details
- Status
- Current
- Company
- Hikma Pharmaceuticals USA, Inc.
- Package NDC
- 0143-9311-10
- Dosage Form
- Injection
- Presentation
- Etomidate, Injection, 2 mg/1 mL (NDC 0143-9311-10)
- Initial Posting
- Oct 5, 2022